Malvern Extends Contract Services in France
News May 25, 2006
Malvern Instruments has extended its provision of contract testing services for particle characterization in France following the conclusion of an agreement with the Laboratoire de Genie Chimique (LGC) based in Toulouse.
The agreement covers services related to both wet and dry particle size analysis. Testing will be carried out by LGC scientists and technicians skilled in the application of advanced particle sizing techniques.
Enquiries about contract services and the initiation of projects will continue to be handled in the first instance by Malvern’s application specialists. Full details can be found on Malvern’s website or by telephoning the company.
Commenting on the new relationship, Jane Bishop, Malvern’s Commercial Director, said, "We are delighted to welcome LGC as a partner as Malvern expands its provision of contract services in France."
"In addition to bringing extensive experience and expertise in particle characterization, LGC’s university connections will help inform our future work to ensure that we offer comprehensive testing services appropriate to the needs of both commercial and academic organisations."
Dr. Joel Bertrand, head of the LGC department said, "Our researchers and technicians have developed considerable expertise, over a long period, in the characterization of dispersed media, mostly using Malvern equipment."
"We believe that this agreement will help us to apply this expertise and extend it to new techniques."
"In addition, we very much expect that via new contacts with the client companies, we will have new opportunities to develop our research in process engineering."
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Rapid and Cost-Effective Instrument that Measures Molecular DynamicsNews
By combining mass spectrometry and thermal desorption, researchers honed a new method to measure excitation and relaxation rates of uracil, the building block of RNA.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE